Examining smoking-induced differential gene expression changes in buccal mucosa by Kupfer, Doris M et al.
RESEARCH ARTICLE Open Access
Examining smoking-induced differential gene
expression changes in buccal mucosa
Doris M Kupfer
1*, Vicky L White




Background: Gene expression changes resulting from conditions such as disease, environmental stimuli, and drug
use, can be monitored in the blood. However, a less invasive method of sample collection is of interest because of
the discomfort and specialized personnel necessary for blood sampling especially if multiple samples are being
collected. Buccal mucosa cells are easily collected and may be an alternative sample material for biomarker testing.
A limited number of studies, primarily in the smoker/oral cancer literature, address this tissue’s efficacy as an RNA
source for expression analysis. The current study was undertaken to determine if total RNA isolated from buccal
mucosa could be used as an alternative tissue source to assay relative gene expression.
Methods: Total RNA was isolated from swabs, reverse transcribed and amplified. The amplified cDNA was used in
RT-qPCR and microarray analyses to evaluate gene expression in buccal cells. Initially, RT-qPCR was used to assess
relative transcript levels of four genes from whole blood and buccal cells collected from the same seven
individuals, concurrently. Second, buccal cell RNA was used for microarray-based differential gene expression
studies by comparing gene expression between a group of female smokers and nonsmokers.
Results: An amplification protocol allowed use of less buccal cell total RNA (50 ng) than had been reported
previously with human microarrays. Total RNA isolated from buccal cells was degraded but was of sufficient quality
to be used with RT-qPCR to detect expression of specific genes. We report here the finding of a small number of
statistically significant differentially expressed genes between smokers and nonsmokers, using buccal cells as
starting material. Gene Set Enrichment Analysis confirmed that these genes had a similar expression pattern to
results from another study.
Conclusions: Our results suggest that despite a high degree of degradation, RNA from buccal cells from cheek
mucosa could be used to detect differential gene expression between smokers and nonsmokers. However the RNA
degradation, increase in sample variability and microarray failure rate show that buccal samples should be used
with caution as source material in expression studies.
Background
Blood has been shown to be a responsive tissue that is
useful for monitoring gene expression changes due to
disease, environmental, biological or drug effects. How-
ever, for studies performed in human subjects, a less
invasive tissue source for biomarker monitoring is of
interest due to the discomfort, required skill level, and
cost of blood collection, especially for repeated-measures
studies. Buccal mucosa (from cheek swabs) is an easily
accessed tissue and has been used successfully to obtain
DNA for genotyping studies [1]. However, the literature
is limited as to the usefulness of RNA from buccal cells
as a substrate for gene expression testing, presumably
due to concern regarding a high concentration of
RNases in saliva which are known to rapidly degrade
RNA in these cells [2]. qPCR has been used to detect
expression changes in genes from the P450 family using
snap frozen surgical buccal plug samples [3] and from
brushed exfoliated buccal cells [4,5]. These studies sug-
gested that buccal cells might serve as an alternative to
blood in qPCR assays examining gene expression pro-
files after exposure to environmental toxins, tobacco
smoke, drugs, nutrients, or the presence of certain can-
cers. With RNA purified from brushed exfoliated buccal
cells, Sridhar et al. [6] used microarrays from smoker
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Gene Expression Omnibus (GEO) collection to compare
expression levels between smokers and nonsmokers, and
to compare expression patterns between buccal cells
and bronchial epithelium in smokers and nonsmokers
from an earlier microarray-based study [7] by Gene Set
Enrichment Analysis (GSEA) [8]. To our knowledge,
buccal cells have not been used in a whole transcrip-
tome approach to investigate differential gene expression
between smokers and nonsmokers using concurrently
harvested samples in a manner which directly compares
expression differences. A successful study of this type
would more clearly suggest that buccal cells have effi-
cacy as source material for biomarker discovery or in a
gene expression monitoring system than earlier studies.
We describe here, both qPCR and microarray
approaches. The RT-qPCR study used matched blood
and brushed buccal samples from the same subjects.
Relative expression levels of four genes allowed compar-
ison of tissue sources and subject differences. RNA from
buccal cells was highly degraded; nonetheless, expres-
sion could be detected by qPCR for all four transcripts
tested. This was sufficient evidence of the potential of
buccal cells to follow up on the work of Sridhar et al.
[6] and use microarrays for differential gene expression
analysis on the transcriptome level in smokers and non-
smokers. An important consideration was the availability
of the Smoking Induced Epithelial Gene Expression
Database, (SEIGE) [7] and smoker buccal mucosa-speci-
fic gene lists [6] against which results from this study
could be compared for confirmation of our method.
Our data was first analyzed for differences between
smokers and nonsmokers using Significance Analysis of
Microarray (SAM) [9] and Rank Product (RP) [10] for
detection of significant gene expression differences
between smokers and nonsmokers in our study. These
analyses resulted in a list of candidate marker genes
from each method. Ingenuity Pathway Analysis [11] was
used to find functional networks containing the differen-
tially expressed genes. The gene lists were also examined
for transcriptional coregulation by searching the promo-
ters of differentially expressed genes for transcription
factor binding sites (TFBS) using PAINT [12] to access
the TRANSFAC [13] database of known TFBS. Specifi-
cally, we identified 103 genes with RP analysis that had
increased expression in smokers. Pathway analysis
showed five function networks involving 91 of the 103
target genes. Network functions included cell cycle; cell
growth, proliferation and movement; gene expression;
and immunological disease. Upstream sequence analysis
showed 38 target genes containing binding sites for at
least one of three widely expressed transcription factors.
Twenty-five genes were identified using SAM analysis.
Similar to the RP results, 13 of these genes fell into one
of two functional networks which had in common roles
in tumor morphology, metabolic disease, lipid and car-
bohydrate metabolism and which contained binding
sites for at least one of two widely expressed transcrip-
tion factors. These results suggest that many of these
genes are co-regulated and that the transcriptional
response affects numerous cellular functions. Both gene
lists were further analyzed using GSEA, to compare the
buccal dataset against the Sridhar gene sets. The com-
parisons showed that the genes in our buccal array data
changed expression in the same direction as in the pub-
lished sets.
The results of the study suggest that buccal mucosa
may indeed be useful for factors selected carefully for
optimum expression change in buccal tissue. However,
the random degradation which may vary between sub-
jects that we encountered suggests a loss of sensitivity,
and possibly the need for multiple sampling which is
costly. It also suggests that due to the extensive degra-




All sample collection was performed with the informed
consent of the study participants under the auspices of
the Federal Aviation Administration Internal Review
Board for approved protocol 08011. Seven subjects pro-
vided matched blood and buccal samples for the qPCR
portion of the study and eight additional female subjects
provided samples for the smoker vs. nonsmoker micro-
array study. Blood samples were collected in PAXgene
Blood RNA tubes (PreAnalytix/Qiagen, Valencia, CA)
according to the manufacturer’s published protocol.
Urine samples for nicotine and cotinine testing were
collected in urine cups without preservative and refri-
gerated until shipping to a clinical lab (Diagnostic
Laboratory of Oklahoma, Oklahoma City, OK). All non-
smokers were below the level of detection for both nico-
tine (10 ng/ml) and cotinine (40 ng/ml). All smokers
showed levels above those expected for smokers which
are concentrations greater than 100 ng/ml for nicotine
and 200 ng/ml for cotinine. See Table 1 for this and
demographic data.
Buccal samples were collected using sterile Cytobrush
Plus® (Medscand Medical; Guttenberg, NJ). Subjects
were asked not to eat for the 30 minutes prior to sam-
pling and rinsed their mouths with a minimum of 20 ml
of water before sample collection. Two buccal samples
were collected from each subject and processed sepa-
rately as either “a” or “b” samples. Cheeks were brushed
for 30 seconds, and the brushes were immediately
plunged into 2 ml tubes containing 1.0 ml of room tem-
perature RNAlater (Invitrogen, Carlsbad, CA) to prevent
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were cut off with sterile surgical scissors such that the 2
ml tubes could be capped. RNA was purified from buc-
cal cell swabs immediately after collection.
RNA Purification
RNA isolation from blood samples was performed
according to the protocol in the PAXgene Blood RNA
Purification Kit [14] with the optional on-column
DNase treatment. A blood total RNA control sample
was created by pooling purified RNA samples from
three individuals not participating in either study.
Buccal-cell RNA was purified using the RNeasy
Micro Kit (Qiagen, Valencia, CA) with the modifica-
tions found in Spivack et al. [5] and here. Cells were
pelleted by centrifugation at 4,000 × g. The brush was
removed from the tube by scraping the bristles against
the lip of the tube to remove any adhered cells and the
pellet reformed by centrifugation as above. RNAlater
was pipetted off the pellet and the pellet washed with
ice-cold PBS and the PBS removed after centrifugation,
as above. Two microliters of polyC (Sigma Chemical;
St. Louis MO) and 350 μl Buffer RLT (RNeasy Micro
Kit) containing 10 μl/ml beta-mercaptoethanol was
added and the pellet passed through a 25 ga needle to
lyse the cells. The lysate was centrifuged at 20,000 × g
for 3 minutes and the supernatant transferred to a
fresh microfuge tube. Then 350 μl7 0 %e t h a n o lw a s
added, mixed well by pipetting and the sample applied
to a MinElute column (RNeasy Micro Kit), and centri-
fuged at 8000 × g for 30 seconds. The column was
washed twice with 350 μl of RW1 buffer (RNeasy Kit)
followed by centrifugation at 8000 × g for 15 seconds.
The column was placed in a fresh 2 ml collection tube
and 500 ul RPE buffer (RNeasy Micro Kit) was added.
The column was centrifuged at 8000 × g for 30 sec-
onds. 500 μl of freshly prepared 80% ethanol was
added the column and centrifuged for 2 minutes at
8000 × g. The column was transferred to a fresh 2 ml
collection tube, with the cap open and centrifuged at
16,000 × g for 5 minutes. The RNA was eluted by add-
ing 30 μl pre-warmed (50-55 degC) RNase-free water
to the membrane. After 2 minutes incubation the col-
umn was centrifuged at 16,000 × g for 2 minutes.
Spectrophotometric analysis showed a large 230 nm
component, potentially salt carryover. To reduce this,
the Qiagen RNeasy Micro Handbook RNA Cleanup
and Concentration protocol (December 2007) was used
as written by the manufacturer for sample volumes
less than 100 μl.
RNA quality was assessed from Agilent Bioanalyzer
2100 (Agilent, Santa Clara, CA) traces using the Agilent
RNA 6000 Nano Series II kit following manufacturer’s
directions with 1 μl of sample to generate a RNA Integ-
rity Number (RIN). Yield was determined on a Nano-
drop 1000 spectrophotometer (Thermo Scientific,
Waltham, MA) (Additional file 1). RNA was aliquoted
and stored at -80 degC.
qPCR
Primers for qPCR in the matched blood and buccal por-
tion of the study were designed using Beacon Designer
7.0 (PREMIER Biosoft International, Palo Alto, CA). Pri-
mers were synthesized and HPLC purified (Integrated
DNA Technologies, Coralville IA). For three genes,
integrin alpha-5/beta-1 (ITGA5), ankyrin repeat domain
28 (ANKRD28), and transmembrane protein 8
(TMEM8), multiple sets of primers were designed to
span the mRNA. For ribosomal protein S3A, (RPS3A)
only a single primer set was designed due to the small
size of the transcript. See Additional file 2 for the pri-
mer sequences, positions of the primer sets on the
respective transcript, concentrations and annealing tem-
peratures. Template material for qPCR was prepared
from 50 ng aliquots of total RNA that were reverse tran-
scribed and amplified using either the WT-Ovation Pico
System or the Ovation RNA Amplification System V2,
#3300, 3100, respectively (Nugen Technologies, Inc., San
Carlos, CA). All qPCR reactions were 25 μla n dp e r -
formed in triplicate with a SYBR® green based based
assay, PerfeCta SYBR Green FastMix, Low ROX,
#95074-05k (Quanta Biosciences, Gaithersburg, MD)
with no additional magnesi u mu s i n g1n go fa m p l i f i e d
template material per reaction except in the amplifica-
tion comparison series where 5 ng/reaction was used.
Cycling was performed on a Stratagene MX3005p (Agi-
lent Technologies, La Jolla, CA) in a 96-well polypropy-
lene plate using optical strip caps (#410098 and 401425
Table 1 Smoker vs. nonsmoker demographics and
nicotine/cotinine levels




NS21 nonmoker 41 cau ND ND
NS22 nonsmoker 44 cau ND ND
NS23 nonsmoker 27 cau ND ND
NS24 nonsmoker 53 cau ND ND
SM25 smoker 53 cau 990 900
SM26 smoker 47 cau > 2500 980
SM27 smoker 39 cau 510 2100
SM28 smoker 50 his > 2500 1000
11Sm* smoker 50 his > 2500 1000
12NS* nonsmoker 44 cau ND ND
Shown is the demography of the female study population used in the
microarray study. No statistical significance was found when ages of smokers
and non-smokers were compared (see results). Also shown are the nicotine
and cotinine levels for each subject (see methods).
* 11Sm and 12NS represent repeat sampling of subjects Sm28 and NS22,
respectively. (cau, Caucasian; his, Hispanic; ND, not detected)
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cycle of 2 minutes 95 degC, 40 cycles of 15 seconds 95
degC, 30 seconds optimum annealing temperature, 15
seconds 72 degC extension, followed by a dissociation
curve with 1 minute 95 degC, 30 seconds at optimum
annealing temperature, and dissociation ramp rate at
0.01 degree/second to 95 degC with all points data col-
lection on. qPCR data was analyzed using qBase version
1.3.5 [15]. qPCR product size was assessed with Agilent
DNA 1000 Series II (Agilent Technologies) microfluidics
chips.
A no reverse transcription control was performed in
duplicate using total RNA in the amount to simulate
what was used after reverse transcription and amplifica-
tion from each sample. The TMEM8 3′-most primers
were used. All reactions failed. The positive control gave
Cts of 22.08 and 22.8.
Microarray target preparation
For microarray target material used in the smoker vs.
nonsmoker portion of the study, 50 ng total RNA was
reverse transcribed and amplified per the manufacturer’s
protocols using the Ovation RNA Amplification System
V2 (Nugen Technologies, Inc.), fragmented and biotin
labeled using the FL-Ovation cDNA Biotin Module V2,
#4200 (Nugen Technologies, Inc.). Gene expression was
determined by hybridization of the labelled template to
hgU133 Plus 2.0 human microarrays (Affymetrix, Inc.,
Santa Clara, CA). Hybridization cocktail synthesis and
post-hybridization processing was performed according
to the “Affymetrix GeneChip Eukaryotic Array Analysis”
protocol found in the appendix of the Nugen protocol
for the fragmentation kit. Arrays were hybridized for 18
hours and washed using fluidics protocol FS450_0004
on a GeneChip Fluidic Station 450 (Affymetrix, Inc.)
Microarray pre-processing
Quality assessment of the arrays was performed with the
tools available in the Gene Chip Operating Software,
version 1.4 (Affymetrix, Inc.) and the Bioconductor
packages AffyQCReport [16] and AffyPLM [17], R ver-
sion 2.8, Bioconductor version 2.3 [18]. The microarray
data has been assigned series number GSE16149 in the
Gene Expression Omnibus (GEO, http://www.ncbi.nlm.
nih.gov/geo/).
Microarray data analysis
Array data were processed with Robust Multiarray Aver-
age (RMA) [19] and quantile normalized using the pack-
age available at the Automated Microarray Pipeline
(AMP) [20]. Differential expression analysis comparing
smokers to nonsmokers was performed with both Sig-
nificance Analysis of Microarrays (SAM) [9] and Rank
Product Analysis (RP) [10], selected for their different
statistical approaches. For RP analysis, samples matching
the two poor quality arrays were removed as this analy-
sis utilizes the ranked expression values from replicate
samples. This left 12 arrays, six in each replicate group,
a and b, for this analysis. Unsupervised hierarchical clus-
tering, T-tests with multiple testing correction, SAM
and RP were performed using the packages available in
the MultiExperiment Viewer, version 4.3.01 (MeV)
[21,22] with default settings. Gene Set Enrichment Ana-
lysis, GSEA version 2.04 [8,23] was used to test the
array data for enrichment of differentially expressed
genes. The default settings were used except the mini-
mum size for gene sets was decreased to ten to allow
analysis against the RP_downSm list which GSEA
reduced from 17. The same microarray differential
expression analysis pipeline was used on the data from
series GSE8987 from the GEO database [6], which were
designated either “mouth”, “never smokers” or “current
smokers”.
The output gene lists of differentially expressed genes
from RP and SAM were evaluated for biological signifi-
cance using Ingenuity Pathway Analysis, IPA (Ingenuity
Systems, Inc., Redwood City CA), for a core analysis.
Promoter Analysis and Interaction Network, PAINT
version 3.6 [12] analysis using the TRANSFAC public
database [13] was used with the same gene lists examin-
ing both strands to 2000 bases upstream looking for
transcription factor binding sites and summing in TREs
any potentially co-regulated genes.
Results
Quality assessment
Initially, we determined the quality of RNA purified
from buccal mucosa. Matched blood and buccal total
RNA from seven subjects was purified (Materials and
Methods). RNA quality was assessed on the Agilent
Bioanalyzer RNA using Nano 6000 chips (Figure 1).
Buccal RNA samples were found to be severely
degraded with RNA Integrity Numbers (RINs) routinely
less than three. In contrast, RINs from the blood sam-
ples were greater than seven in all cases (Additional file
1). These results indicate that buccal RNA was not of
high quality.
Evaluation by qPCR
To determine if RNA from buccal cells could be useful
for marker analysis, we chose to perform qPCR on these
paired samples. Primers to four genes were used:
ITGA5, ANKRD28, TMEM8, and RPS3A. Primers to
these genes had been designed previously by our group
for another qPCR study and were found to yield detect-
able signal using total RNA from blood (unpublished
results). BioGPS [24] values for these four genes indi-
cated an approximate expected ratio of buccal cells
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These four genes appeared to represent a range of
mRNA prevalence in salivary gland which we felt was
useful in determining our qPCR limitations with the
buccal material. Primers were designed to the 3′ ends of
all four genes. To determine whether RNA degradation
was random or specific by gene region, primers to
Figure 1 Representative qPCR matched blood and buccal mucosa samples. The buccal RNA (cheek) appears to be heavily degraded
compared to the blood RNA since there is no evidence of 18 or 28S rRNA peaks and the bulk of material is migrating rapidly indicating small
size. RIN, RNA integrity number; NA, no RIN determination possible.
Table 2 BioGPS expression values for blood and salivary
gland for genes tested via qPCR
ANKRD28 TMEM8 RPS3A ITGA5
Salivary gland 130 2000 60,000 2000
Blood 130 7000 > 100,000 7000
Values are approximate signal strength values from BioGPS using the Human
U133A gcRMA dataset [24].
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were also designed (Additional file 2).
The WT Ovation Pico kit containing random primed
hexamers and poly-T primers was used for amplification
of all fourteen samples, both blood and buccal, and the
subsequent product used for qPCR with the primer
pairs detailed above. An average over the seven subjects
showed that there was a lower apparent transcript copy-
number for each tested gene in buccal mucosa RNA
than in blood RNA (Table 3). In some subjects, no Ct
was calculated and the differences between apparent
transcript levels are greater than the mean value indi-
cates. As seen from the increased standard deviations,
RNA from buccal cells had greater variability in Cts,
suggesting that buccal RNA quality is more variable
than blood RNA.
When specificity of degradation was investigated, no
clear pattern was evident. ITGA5 showed a 32-fold
difference from 5′ to 3′ in buccal mucosa compared to
an approximately three-fold difference in blood, but
most reactions with ITGA5 primers with buccal RNA
failed. ANKRD28 and TMEM8 showed no change in 5′/
3′ ratio in either RNA source. Due to the short tran-
script length of RPS3A, no 5′ primer set was designed.
This initial analysis of the quality of buccal RNA shows
that, in general, there were lower but detectable levels
of target mRNA in buccal mucosa when compared to
blood (Table 3). These results do not differentiate
between tissue-specific expression differences or degra-
dation; however, when the expression data from BioGPS
and the RINs are factored into our analysis, the differ-
ences in Cts are greater than expected from expression
data and likely due to degradation. The variability of
results from buccal cells suggests that the degradation
seen in the buccal samples is not occurring in a predict-
able directional fashion but randomly such that
Table 3 qPCR results comparing blood and buccal RNA across four genes with WT amplified template
TMEM8 ANKRD ITGA5 RPS3A
_2067* _1372 _584 _4387 _2552 _1345 _3879 _1994 _198
Subject
Buccal 1 33.76 No Ct 34.93 No Ct 30.33 28.91 31.7 No Ct 31.86
Buccal 2 29.72 29.15 26.83 31.64 29.52 27.47 No Ct No Ct 28.65
Buccal 3 28.18 30.52 29.27 30.81 35.73 30.13 No Ct 38.64 28.49
Buccal 4 24.96 27.74 28.09 31.8 33.55 31.98 35.71 No Ct 26.82
Buccal 5 25.31 26.56 26.39 31.36 32.8 34.02 No Ct No Ct 27.38
Buccal 6 35.22 34.85 34.1 No Ct No Ct 37.42 No Ct No Ct ND
Buccal 7 29.05 29.24 35.31 No Ct No Ct No Ct No Ct No Ct 33.19
Mean 29.46 29.68 30.7 31.4 32.39 31.66 33.71 38.64 394
StDev 3.61 2.63 3.65 0.38 2.24 3.32 2.01 0 2.33
Blood 1 27.03 26.49 25.78 30.58 29.28 30.36 24.86 26.67 26.31
Blood 2 28.5 28.28 26.58 29.04 28.87 28.86 24.41 26.42 26.66
Blood 3 28.08 27.71 26.7 29.03 29.93 28.33 24.28 25.34 26.1
Blood 4 27.64 26.53 26.57 29.43 29.61 29.68 25.14 25.62 27.11
Blood 5 27.3 27.63 25.32 29.82 28.71 28.89 24.72 25.29 26
Blood 6 27.96 27.67 26.02 29.68 29.09 29.45 26.69 28.92 ND
Blood 7 27.8 28.48 27.62 29.49 28.73 28.06 24.34 27.14 26.82
Mean 27.76 27.57 26.37 29.57 29.17 29.09 24.92 26.49 26.5
StDev 0.46 0.78 0.69 0.48 0.43 0.74 0.78 1.19 0.4
Controls^
NTC 39.4 No Ct No Ct No Ct No Ct No Ct No Ct No Ct No Ct
WT amplification 28.4 27.28 26.45 29.47 29.23 29.48 24.63 26.59 2594
3’ amplification 26 22.9 24.4 20.5
Product (bp) 179 110 118 199 150 143 104 107 276
mRNA (bp) 2529 2529 2529 6339 6339 6339 4248 4248 903
Results are in Ct values from the four genes used in initial expression assessment by qPCR. Results shown are the average value from three replicates for each
primer pair as input material from each subject.
* Primers used in qPCR are given by gene heading followed by 5’ position of amplification on mRNA. See Additional file 1.
^ NTC, No template control; WT whole transcriptome, and 3’ Positive Controls are RNA from pooled blood samples
(ND, not done; bp, basepair)
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dation seen.
The reduced signal detected in buccal versus blood
samples with the WT amplification method led us to
hypothesize that a 3′-specific amplification would
increase the sensitivity of expression assays by increasing
the specificity of the reverse transcription step for
mRNAs. With the level of degradation found in buccal
samples, rRNA peaks are not detectable in electrophero-
grams and presumably would be reduced in their nor-
mal high degree of secondary structure. The degraded
rRNA would be accessible to the random primers used
in whole transcriptome amplification; however, the poly-
T primers used in the 3′ amplification approach would
not anneal to the fragmented rRNA but be specific for
polyA tails of mRNA. This would result in a difference
in Ct between the template types, higher when a large
percent of the cDNA is ribosomal in origin as opposed
to lower Ct values when 3′ amplified material is used.
To investigate this possibility, the same samples were
amplified with the Ovation RNA Amplification System
V2, a 3′ specific method. Table 4 shows a comparison of
the qPCR results using the 3′ targeted primers and both
buccal mucosa and blood derived RNA template. For all
three genes 3′ amplification resulted in a Ct decrease, i.
e. an apparent increase in copy number, although Cts
from buccal mucosa RNA tested with primers to ITGA5
remained greater than 31. Relative Cts from ANKRD28
and TMEM8 between buccal RNA and blood RNA
compare favourably with data from BioGPS comparing
salivary gland to whole blood. However, ITGA5 values
did not correspond particularly well suggesting that
ITGA5 was more sensitive to degradation than the
other genes tested or than salivary gland data in BioGPS
is not predictive for buccal mucosa.
Microarray study
Our ability to detect expression of genes by qPCR, most
at levels well above background, in 3′ amplified samples
led us to hypothesize that buccal samples could be used
for differential expression testing by microarray analysis.
Amplification of buccal RNA samples eliminates the
need for repeated sample collection and/or pooling of
material from multiple collections. The work of others
[5,6] led to the further hypothesis that a comparison of
smokers and nonsmokers was a model system likely to
allow detection of differentially expressed genes. Affyme-
trix hgU133 plus 2.0 arrays were used for a global eva-
luation of gene expression changes between four
smokers and four nonsmokers. Only female subjects
were used to prevent any gender bias in the data and
both cheeks from each subject were sampled. Addition-
ally, an unpaired t-test was performed that showed no
statistical significance between the two subject groups
based on age (p-value = 0.3737). Total RNA was isolated
and evaluated for quality as for the qPCR samples. One
cheek sample from each subject was arbitrarily assigned
to one of two groups, a or b (Materials and Methods).
Figures 2 and 3 show the BioAnalyzer traces from all 16
samples along with a trace representative of the RNA
quality usually purified from blood. As seen with the
samples used in the qPCR study, the samples show no
evidence of rRNA peaks, and a range of degradation
product sizes; in only a third of the samples could a
RIN be calculated (Additional file 1).
Quality assessment of the arrays
Following hybridization each array was examined for
quality. Table 5 lists the percent present (%p) and scal-
ing factor (SF) values determined using the Gene Chip
Operating Software (Affymetrix, Inc.; Materials and
Methods). Two arrays, NS21a and Sm27a had remark-
ably low %p and especially high SFs, both indicators of
arrays with suspect data quality. Additionally, the same
two arrays had much lower signal intensities (Figure 4).
The normalized unscaled standard error (NUSE) [25]
calculations had high median values and large interquar-
tile range for these two arrays (Table 5). Samples from
the same subjects’ opposite cheek did not show the
same set of quality control issues, further evidence that
RNA quality from buccal cells is inconsistent. Neither
sample could have been predicted to be of lesser quality
from the BioAnalyzer traces (Figures 2 and 3). Due to
the poor quality of these two arrays, they were removed
from further analysis. Two other arrays, Sm28a and b,
had elevated NUSE parameters compared to other
Table 4 qPCR results comparing methods of template amplification
Template Itga5b 3’ Itga5b WT Tmem8 3’ Tmem8 WT Ankrd28 3’ Ankrd28 WT
Buccal 4 31.25 39.15 20.38 24.96 20.68 31.8
Buccal 5 35.81 No Ct 20.36 25.31 20.92 31.36
Blood 4 21.43 23.96 21.87 30.68 20.33 29.43
Blood 5 20.56 23.9 21.11 30.23 20.22 29.82
Control 21.18 23.8 21.63 28.4 20.23 29.47
All amplifications were performed using either the Ovation V2 (3’) or WT pico Nugen Kits, see Materials and Methods. Control RNA is from a pooled blood
sample, see Materials and Methods.
Kupfer et al. BMC Medical Genomics 2010, 3:24
http://www.biomedcentral.com/1755-8794/3/24
Page 7 of 14subjects but did not have a low %p or high SF, and so
were not removed as the observed differences were
likely subject dependent and are more likely due to bio-
logical diversity between subjects.
Microarray data analysis for differential expression
A study using Affymetrix hgU133A arrays to compare
gene expression in “current smokers” and “neversmo-
kers” using RNA from buccal mucosa and nasal swabs
was published by Sridhar et al. [6]. This group per-
formed an extensive microarray analysis of gene expres-
sion in bronchial lavage samples from current smokers,
former-smokers and never-smokers and developed a list
of 314 genes differentially expressed in smokers in this
tissue [7,26]. Using Gene SetE n r i c h m e n tA n a l y s i s
(GSEA), Sridhar examined the smoker buccal and nasal
microarray data asking whether the genes on the bron-
chial-314 gene list showed the same direction of change
and identified three leading-edge subsets of genes from
the bronchial-314 list which were changing expression
in the buccal or nasal data in the same direction as in
the bronchial data. These were a 74 gene subset up-
regulated in buccal mucosa of smokers, a 120 gene
subset up-regulated in the nasal mucosa of smokers and
a 50 gene subset down-regulated in nasal mucosa of
smokers. The buccal microarray cel files were down-
loaded from GEO and analyzed in parallel with the data
from the current study (Materials and Methods). Initi-
ally, unsupervised hierarchical clustering was performed
with the summarized data from the current study,
termed SmvsNS, and BuccalCompare for the Sridhar
study. Neither dataset showed any pattern of clustering
b yr e p l i c a t es a m p l e( av s .b )i nt h ec a s eo ft h eS m v N S
data, nor by smokers and non-smokers in either dataset.
T-tests comparing the a samples to the b samples in
the SmvsNS data were done to evaluate the within-sub-
ject variability. There were 871 significant probesets out
of 53,800 or 1.62%. Comparing smokers to nonsmokers
using the same test gave 178 probesets or 0.33%. Apply-
ing a t-test to the BuccalCompare data gave 65 differen-
tially expressed probesets comparing never smokers to
current smokers and 66 probesets when a random
grouping of odd numbered arrays against even was com-
pared. Taken together, these results suggest that there is
at least as much or greater variability among subjects
than smoking introduces between the two subject types.
Figure 2 Buccal mucosa total RNA from smokers and nonsmokers, the group a buccal cell samples. Note variation between the isolates
in peak heights and species. Sm Smokers, NS nonsmoker. Sample 1, whole blood total RNA as seen in Figure 1 for comparison, showing 18S
and 28S ribosomal peaks. RIN, RNA integrity number; NA no RIN determination possible.
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Page 8 of 14SAM [9] and RP [10] were used to develop lists of dif-
ferentially expressed genes between smokers and non-
smokers. With the SmvNS data, SAM returned 30
s i g n i f i c a n tp r o b e s e t sw i t haQv a l u eo f0a ta1 0 %F D R .
All 30 probesets were up-regulated in smokers. For the
BuccalCompare dataset there were no significant results
from the SAM analysis. With RP analysis of the SmvNS
data seventeen genes were found to be down-regulated
and 118 genes up-regulated in smokers (Additional file
3). RP analysis could not be performed on the Buccal-
Compare dataset since there were no replicates.
Only a few genes were found to be in common
between the up-regulated gene lists (Figure 5) [27]. The
RP_downSm gene list had no overlap with the corre-
sponding Sridhar Nasal_downSm leading edge set. Note
that the probesets for the genes on the SAM_upSm and
the RP_upSm lists have similar fold change ranges and
medians, but probesets in the RP_downSm differed in
having overall low signal strength (Additional file 4).
Using a similar analysis approach to Sridhar, both the
SmvsNS and the BuccalCompare datasets were com-
pared against six gene lists in a GSEA enrichment
analysis. The gene lists were the 74 genes in Bucca-
l_upSm, the 120 genes in Nasal_upSm and the 49 genes
in Nasal_downSm defined as leading edge subsets by
Sridhar [6], the 25 genes in SAM_upSm, the 107
RP_upSm genes, and the 17 genes in RP_downSm the
three lists from the current study (Additional file 3).
When GSEA analysis of the SmvsNS dataset was per-
formed against all six gene lists, the four lists up-regu-
lated in smokers showed the same expression patterns
in the SmvsNS dataset, and the two down-regulated
gene lists likewise were down-regulated in the SmvsNS
dataset. The same analysis was performed using the
BuccalCompare data against the same six gene lists with
the same results. This showed correlation between the
SmvsNS and BuccalCompare datasets in terms of the
direction of gene expression change for genes in the six
sets. In the SmvsNS comparison the SAM_upSm list
genes were significantly enriched in the smoker pheno-
type with an FDR q-value 0.029 and p-value 0.025 but
n o tt h eR P _ u p S mg e n e sw h i c hs h o w e da nF D Rq - v a l u e
0.3. This was unexpected since the RP_upSm gene list
was derived from the SmvsNS dataset. The
Figure 3 Buccal mucosa total RNA from smokers and nonsmokers, the group b buccal samples. Sample 1, total RNA from whole blood is
added for comparison. Compare to Figure 2. For example Sm26a and Sm26b are from opposite cheeks of same subject and show some
similarity in migration pattern. The same variation in peak heights and species between samples is seen here as in Figure 2. RIN, RNA integrity
Number; NA, no RIN determination possible.
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Page 9 of 14BuccalCompare data behaved similarly with only the
Buccal_upSm gene list statistically significantly enriched.
This was expected since it was derived from this dataset.
As a check for reproducibility, two subjects, one smo-
ker and one nonsmoker, both cheeks, were retested sev-
eral months after the initial sampling was performed.
Four arrays were generated (11Sm a, b and 12NS a, b).
This small dataset was examined with GSEA against the
same six gene sets. The results showed that this
repeated subset had significant gene enrichment for
smokers with the RP_upSm, Nasal_upSm and Bucca-
l_upSm gene lists with a nominal p-value of 0, an indi-
cation of good reproducibility.
Function analysis
To further evaluate the gene lists derived from the
SmvsNS dataset for biological coherence the SAM and
RP gene lists were evaluated for over-representation of
transcription factor binding sites in the promoters of
these genes using the Promoter Analysis and Interactive
Tool Set, (PAINT) [12,28], Materials and Methods, and
for shared functional interactions using Ingenuity Path-
ways Analysis, (IPA) (version 7.0, Copyright 2009 Inge-
nuity Systems, Inc., Redwood City CA). Statistically
significant transcriptional regulation elements (TREs)
were found with 15 of the SAM_upSm and 42 RP_upSm
genes. No TREs were found for genes in the
RP_downSm genes.
In IPA, 17 of the 25 genes from SAM_upSm formed
two initial networks sharing broad functional categories
including tumor morphology, lipid metabolism,
Table 5 Microarray quality metrics
Samples Scaling Factor % Present NUSE Median NUSE IQR
Smokers
25a 24.6444 35.9 0.989 0.021
25b 4.532 47.8 0.991 0.021
26a 19.022 31.8 0.989 0.02
26b 3.451 30 1.013 0.04
27a 255.647 6 1.101 0.089
27b 3.713 49.9 0.985 0.021
28a 12.806 22.5 1.027 0.046
28b 4.674 24 1.061 0.073
Nonsmokers
21a 307.934 3.5 1.12 0.097
21b 6.852 35 1 0.024
22a 22.185 40.7 0.998 0.019
22b 4.808 47.6 0.993 0.022
23a 20.057 33.6 0.987 0.02
23b 4.689 44.5 0.991 0.022
24a 21.886 39.5 0.988 0.02
24b 3.926 50.9 0.988 0.021
In bold, values indicating poor quality array. Scaling Factor and % Present
were determined with GCOS. NUSE, [25] was determined by probe level
modelling using the Bioconductor AffyPLM package, see Materials and
Methods; IQR, interquartile range.
Figure 4 Replicate Samples a and b Raw Signal Value Histograms. Two arrays, NS21a and Sm27a have low overall signal strength as shown
by the intensity plot. The arrays from the matching b cheek NS21b and Sm27b show acceptable values. Note the difference in y-axis density
scale. NS nonsmoker, Sm smoker.
Kupfer et al. BMC Medical Genomics 2010, 3:24
http://www.biomedcentral.com/1755-8794/3/24
Page 10 of 14carbohydrate metabolism, and small molecule biochem-
istry that could be merged into a single large network.
T h eR P _ d o w n S mg e n e sd i dn o tr e s u l ti na n yf u n c t i o n a l
networks when examined in IPA. However, 91 of the
genes on the RP_upSm list fell into five networks which
could be merged into a single large network, indicating
shared function. Functional categories for this network
included: cell growth, movement, development and
death; cell cycle; gene expression, cancer and immunolo-
gical system development and function.
As a final step in the analysis, genes in TRE networks
from PAINT were coded for network function from IPA
(Figure 6 and 7). This analysis strongly suggests co-reg-
ulation within functional networks and speaks to the
transcriptional affects of smoking on buccal cells.
Discussion
This study was focused on determining whether the
buccal mucosa could serve as a tissue source for total
R N At ob eu s e di nr e l a t i v eg e n ee x p r e s s i o ns t u d i e s
and biomarker detection by qPCR and microarray ana-
lyses. Two previous studies had suggested that buccal
cells had efficacy for measuring responses to tobacco
smoke exposure [5,6] and suggested extrapolation of
this tissue source to other inhalation or ingestion
exposures [5].
Our initial RNA isolations from matched blood and
buccal RNA showed a marked difference in the quality
of the isolated material between the two sources and
showed that there was significant degradation in buccal
mucosa RNA. The qPCR results from the matched sam-
ples showed an average lower copy number in buccal
RNA than blood RNA for all four genes tested and
greater variability between subjects (Table 3). The lower
Figure 5 Venn diagram showing overlap among the four gene
lists upregulated in smokers.
Figure 6 A graphic showing the PAINT TRE for the SAM_upSm gene list. Color has been added to indicate membership in a particular IPA
functional network. Thirteen of the 25 SAM_upSm target genes are contained in both IPA and PAINT analyses. The ovals represent target genes
identified by PAINT as having transcription factor binding sites upstream of the gene. The color of the oval corresponds to the functional
networks in which IPA placed the gene. The two gray ovals represent genes not included in the IPA network. The rectangles indicate
transcription factors. Arrows connect the transcription factors to genes with corresponding upstream binding sites.
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Page 11 of 14copy-number was expected as salivary glands express all
four genes at the same or lower level as blood on micro-
arrays (Table 2); however, the increased variability found
between buccal samples, including duplicate samples
from the same subject over blood is a concern.
The amplification protocols utilized here allow buccal
cell samples to be used in repeated measures experi-
ments removing the necessity to sample more than once
to obtain sufficient template for a single microarray.
The fifty nanograms of RNA we used for amplification
can routinely be isolated from a single swab (Additional
file 1) and the resulting amplified cDNA is sufficient for
an array as well as other procedures such as qPCR. This
is in contrast to the multiple sampling and pooling from
the same individual required by Sridhar et al. [6] where
amplification was not used. Additionally, there was an
advantage to using 3′-amplification over a whole tran-
scriptome approach with the degraded buccal RNA pos-
sibly due to a reduction in the rRNA contribution to
the amplified product.
In most cases, the array quality was acceptable but
with buccal RNA, arrays did have a higher failure rate
than is typical for arrays hybridized with target material
from blood RNA. Two of 16 samples failed where
matching samples from the other cheek passed. This
opens the possibility that samples from both cheeks
would be required to insure that every sample was col-
lected in a study. However, we found the intra-subject
variability to be high as well. The availability of the Srid-
har buccal dataset provided comparison data and along
with the previous work from this group [7], also pro-
vided published lists of genes from buccal and nasal
cells which change expression levels due to smoking.
Gene lists developed from the current study did not
overlap extensively with each other or with the Sridhar
lists. However, using the independent analysis tools
PAINT and IPA a cohesive function/cotranscription net-
work was generated suggesting two non-random sets of
genes upregulated in smokers. Transcription factor
binding site analysis is a good complement to a func-
tional analysis such as IPA because it has no ap r i o r i
assumptions about gene function relying instead on pro-
moter sequence alone. The analysis results suggested
that using an approach which included these two
Figure 7 A graphic showing the PAINT TRE for the RP_upSm gene list. Thirty-eight of 103 RP_upSm target genes are contained in both IPA
and PAINT analyses. The ovals represent target genes identified by PAINT as having transcription factor binding sites upstream of the gene. The
color of the oval corresponds to the functional networks in which IPA placed the gene. The four gray ovals represent genes not included in the
IPA network. The rectangles indicate transcription factors. Arrows connect the transcription factors to genes with corresponding upstream
binding sites. Compare to figure 6.
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Page 12 of 14complementary methods is useful for evaluating candi-
date genes.
The analysis conducted with GSEA was significant
because there was perfect concordance between gene
lists derived from each of the two datasets for the direc-
tion of change in expression between smokers and non-
smokers. The results from the small repeated dataset
were an indication of reproducibility with this system.
This validated the methods used in the current study to
discover differentially expressed genes. However, the
lack of consistent statistically significant enrichment for
the smoker phenotype with GSEA analysis taken with
the degradation in RNA derived from buccal cells high-
light the difficulties to be expected when using buccal-
cell RNA for differential expression testing.
Conclusions
The work presented here was a straightforward evalua-
tion of buccal mucosa as a tissue useful for evaluating
relative gene expression changes using an analysis
scheme containing well validated and commonly used
analysis tools. Isolation and amplification techniques
were successfully modified from those used with whole
blood. The level of degradation found was not unex-
pected; nevertheless, we were able to successfully per-
form qPCR with the buccal RNA. Somewhat surprising
was that, given the poor quality of the RNA, the quality
of the majority of the microarrays was acceptable and
that several lists of genes showing change in expression
in smokers compared to nonsmokers resulted from sta-
tistical analysis of the arrays. There was evidence of
reproducibility in expression change but the borderline
statistical significance level of the lists clouds the validity
of the findings. Our findings suggest that this may be a
difficult tissue to use, requiring replicate sampling and
arrays, which may perform better using a different tech-
nology such as an array format or amplification method
designed for heavily degraded template material. How-
ever, using buccal tissue RNA with 3′ amplification may
b eas u i t a b l et i s s u ec h o i c ea nd preparation approach
when assaying specific highly differentially expressed
gene targets which could overcome the limitations of
subject variability and sample degradation.
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